Serum IL-17 and postmenopausal osteoporosis

Authors

  • Tharwa H. AL-Tai Dept. of Biology /College of Medicine/University of Baghdad.

DOI:

https://doi.org/10.32007/jfacmedbagdad.574394

Keywords:

Postmenopasual, Osteoporosis, IL-17.

Abstract

Background: Osteoporosis is a bone condition that makes bones thininer and more fragile because of reduced bone density and it puts people at risk of fractures, especially of the hip, spinal vertebrae and wrist.
Objective: This study will highlighted the role of IL-17 in postmenopausal osteoporosis.
Patients and methods: This study applied on 84 includes subjects (42 postmenopausal osteoporosis patient and 42 of healthy control group), conducted from December 2014 to March 2015 to measure the IL-17 serum level by using ELISA kit.
Results: In osteoporotic postmenopausal women the mean of serum IL-17 was (0.49pg/ml) and it is significantly higher than that of healthy group (0.09pg/ml).
Conclusion: Serum IL-17 was significantly elevated in osteoporotic postmenopausal women when compared to healthy postmenopausal women.

Downloads

Download data is not yet available.

Downloads

Published

2016-01-03

How to Cite

1.
Serum IL-17 and postmenopausal osteoporosis. JFacMedBagdad [Internet]. 2016 Jan. 3 [cited 2024 Mar. 29];57(4):299-301. Available from: https://iqjmc.uobaghdad.edu.iq/index.php/19JFacMedBaghdad36/article/view/394

Similar Articles

1-10 of 482

You may also start an advanced similarity search for this article.